- Forums
- ASX - By Stock
- TLX
- Ann: ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU
Ann: ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU, page-12
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$19.86 |
Change
-0.080(0.40%) |
Mkt cap ! $6.620B |
Open | High | Low | Value | Volume |
$19.77 | $20.47 | $19.66 | $23.34M | 1.167M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 3329 | $19.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.86 | 1996 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 2156 | 19.850 |
23 | 3029 | 19.840 |
8 | 975 | 19.830 |
7 | 2744 | 19.820 |
7 | 1732 | 19.810 |
Price($) | Vol. | No. |
---|---|---|
19.860 | 2585 | 23 |
19.870 | 1963 | 15 |
19.880 | 934 | 7 |
19.890 | 1212 | 13 |
19.900 | 1557 | 11 |
Last trade - 15.30pm 16/07/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |